CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06096168
NCT06096168N/ACompleted

Ambispective Study Evaluating the Clinical Results of SAGITTA EVL R Revision Stems

Societe dEtude, de Recherche et de Fabrication·observational·Posted Oct 23, 2023·Updated Jun 25, 2025

In Brief

An observational study for Hip Arthropathy. Completed, enrolled 42 participants across 1 site.

Detailed Summary

This clinical study is conducted to collect data on hip arthroplasty with the SAGITTA EVL-R revision femoral stems manufactured by SERF. In order to reflect current practice, a comprehensive and continuous series of patients will be included. This study will confirm the performance and safety of the SAGITTA EVL R revision femoral stems within the framework of MDR 2017/745 and in relation to the recommendations of the MEDDEV guide 2.7.1. Rev 4 (Clinical Evaluation Guide), which provides for a systematic procedure to monitor clinical data in order to verify the claimed performance of medical devices.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHip Arthropathy
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedOct 23, 2023
Enrollment StartApr 13, 2023
Primary CompletionOct 29, 2024
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 2.7 years ago